ARTICLE | Deals
U.K. partners to accelerate gene therapy development for dementia
CGT Catapult, UK DRI to work with academic centers to identify assets
June 20, 2022 11:56 PM UTC
A new partnership in the U.K. aims to drive the development of gene therapies for dementia-related diseases.
The Cell and Gene Therapy Catapult and the UK Dementia Research Institute partnered Monday to identify AAV-based gene therapies for dementia in collaboration with U.K. academic centers of excellence. After identifying programs, the partners will create development plans for each project with the potential for further early-stage research ahead of any investment for future development. ...